Capitalizing a Cure how finance controls the price and value of medicines
"Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. Bu...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Oakland, California :
University of California Press
2023.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009720254206719 |
Tabla de Contenidos:
- Preface : pandemics, Wall Street, and the value playbook
- Introduction : the politics of drug pricing and the value of a cure
- Capitalizing science : public knowledge into pharmaceutical assets
- Capitalizing drugs : shareholder power and the cannibalizing company
- Capitalizing health : the struggle over value and treatment access
- From financialization to public purpose for health
- Conclusion : reckoning with pharmaceutical value in crisis times.
